These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36932129)

  • 81. Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA.
    Neumayer C; Ng D; Jiang CS; Qureshi A; Lalazar G; Vaughan R; Simon SM
    Clin Cancer Res; 2023 Jan; 29(1):271-278. PubMed ID: 36302174
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A case of fibrolamellar cancer with a palliative response and minor radiographic regression with erlotinib and bevacizumab combination therapy.
    Fakih M
    Am J Ther; 2014; 21(6):e207-10. PubMed ID: 23676344
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association.
    De Gaetano AM; Nure E; Grossi U; Frongillo F; Russo R; Vecchio FM; Lirosi MC; Sganga G; Felice C; Bonomo L; Agnes S
    Jpn J Radiol; 2013 Oct; 31(10):706-12. PubMed ID: 23852711
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
    Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
    Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
    Sárosi I; Kiss A; Schaff Z; Lapis K
    Acta Morphol Hung; 1991; 39(4):321-31. PubMed ID: 1668901
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clavicle tumor as an initial manifestation of fibrolamellar hepatocellular carcinoma.
    Cebrián A; Elosua A; González-de la Higuera B; Irisarri R; Ruiz-Clavijo D
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(1):104-106. PubMed ID: 31677896
    [No Abstract]   [Full Text] [Related]  

  • 87. Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients.
    Hu J; Wang Y; Deng L; Yu H; Chen K; Bao W; Chen K; Chen G
    Updates Surg; 2022 Oct; 74(5):1589-1599. PubMed ID: 35713784
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.
    Malouf GG; Job S; Paradis V; Fabre M; Brugières L; Saintigny P; Vescovo L; Belghiti J; Branchereau S; Faivre S; de Reyniès A; Raymond E
    Hepatology; 2014 Jun; 59(6):2228-37. PubMed ID: 24443104
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management.
    Aziz H; Brown ZJ; Panid Madani S; Kamel IR; Pawlik TM
    J Am Coll Surg; 2023 Feb; 236(2):399-410. PubMed ID: 36648268
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
    Kakar S; Burgart LJ; Batts KP; Garcia J; Jain D; Ferrell LD
    Mod Pathol; 2005 Nov; 18(11):1417-23. PubMed ID: 15920538
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Is hepatocellular carcinoma the same disease in children and adults? Comparison of histology, molecular background, and treatment in pediatric and adult patients.
    Weeda VB; Aronson DC; Verheij J; Lamers WH
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27475. PubMed ID: 30259629
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Targeting BCL-XL in fibrolamellar hepatocellular carcinoma.
    Shebl B; Ng D; Lalazar G; Rosemore C; Finkelstein TM; Migler RD; Zheng G; Zhang P; Jiang CS; Qureshi A; Vaughan R; Yarchoan M; de Jong YP; Rice CM; Coffino P; Ortiz MV; Zhou D; Simon SM
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 36073545
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MDM4 expression in fibrolamellar hepatocellular carcinoma.
    Karki A; Putra J; Kim SS; Laquaglia MJ; Perez-Atayde AR; Sadri-Vakili G; Vakili K
    Oncol Rep; 2019 Oct; 42(4):1487-1496. PubMed ID: 31322272
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.
    Barshack I; Meiri E; Rosenwald S; Lebanony D; Bronfeld M; Aviel-Ronen S; Rosenblatt K; Polak-Charcon S; Leizerman I; Ezagouri M; Zepeniuk M; Shabes N; Cohen L; Tabak S; Cohen D; Bentwich Z; Rosenfeld N
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1355-62. PubMed ID: 20619223
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching.
    Qiu S; Chen R; Hu J; Han T
    Scand J Gastroenterol; 2023; 58(11):1351-1358. PubMed ID: 37353942
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Fibrolamellar hepatocellular carcinoma: a rare but distinct type of liver cancer.
    Andersen JB
    Gastroenterology; 2015 Apr; 148(4):707-10. PubMed ID: 25724459
    [No Abstract]   [Full Text] [Related]  

  • 97. Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers.
    Mulazzani L; Alvisi M
    Transl Cancer Res; 2019 Apr; 8(Suppl 3):S297-S310. PubMed ID: 35117109
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Fibrolamellar hepatocellular cancer].
    Ormann W
    Leber Magen Darm; 1993 May; 23(3):128-31. PubMed ID: 8392127
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Synchronous wilms tumor and fibrolamellar hepatocellular carcinoma: report of a case.
    Maitra A; Ramnani DM; Margraf LR; Gazdar AF
    Pediatr Dev Pathol; 2000; 3(5):492-6. PubMed ID: 10890935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.